Drug Monitoring, Panel 4, Screen, Urine
Test Code
Clinical Significance
Drug Monitoring, Panel 4, Screen, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient ...
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Amphetamines, Barbiturates, Benzodiazepines, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine
Specimen validity consisting of Creatinine, Oxidant, and pH testing.
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
30 mL urine
Alternative Specimen(s)
Urine collected in urine collection container
Minimum Volume
7 mL
Transport Container
Clinical drug test transport vial
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 5 days
- Refrigerated: 7 days
- Frozen: 30 days
Reject Criteria
Preserved samples
Setup Schedule
Refrigerated: 7 days
Frozen: 30 days